Displaying drugs 12576 - 12600 of 12870 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Umirolimus | 986.294 C55H87NO14 | Not Annotated | Anti-Inflammatory Agents / Immunosuppressive Agents | |
Carbetocin | 988.161 C45H69N11O12S | An oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth. | Oxytocin and Analogues | |
Rose bengal I-131 | 989.67 C20H4Cl4I4O5 | Not Annotated | Radiopharmaceuticals | |
Ridaforolimus | 990.222 C53H84NO14P | Investigated for use/treatment in solid tumors, sarcoma, cancer/tumors (unspecified), endometrial cancer, prostate cancer, and bone metastases. | Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors | |
bis(molybdopterin)tungsten cofactor | 990.77 C20H20MgN10O12P2S4W | Not Available | Not Available | |
S-(2-oxo)pentadecylcoa | 991.916 C36H64N7O17P3S | Not Available | Not Available | |
Demoxytocin | 992.18 C43H65N11O12S2 | Not Annotated | Oxytocin and Analogues | |
Gantacurium | 993.58 C53H69ClN2O14 | Investigated for use/treatment in anesthesia (unspecified). | Anticholinergic Agents / Central Nervous System Depressants / Heterocyclic Compounds, Fused-Ring / Muscle Relaxants / Muscle Relaxants, Peripherally Acting Agents / Nicotinic Antagonists | |
Atosiban | 994.19 C43H67N11O12S2 | An inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations. | Hormone Antagonists / Tocolytic Agents | |
ABT-510 | 994.2317 C46H83N13O11 | Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors. | Amino Acids, Peptides, and Proteins / Peptides | |
5-Mercaptoethanol-2-decenoyl-coenzyme A | 994.877 C33H55N7O18P3S2 | Not Available | Not Available | |
Odalasvir | 1001.286 C60H72N8O6 | Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection. | Antiviral Agents | |
Gadofosveset trisodium | 1003.85 C33H38GdN3Na5O14P | An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. | Paramagnetic Contrast Media | |
Calyculin A | 1009.185 C50H81N4O15P | Not Available | Carcinogens / Enzyme Inhibitors / Phosphoprotein Phosphatases, antagonists & inhibitors / Vasoconstrictor Agents | |
CoA-S-trimethylene-acetyl-tryptamine | 1009.85 C36H54N9O17P3S | Not Available | Not Available | |
Gallium Ga-68 gozetotide | 1011.909 C44H59GaN6O17 | A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography. | Gallium Radioisotopes / Radioactive Diagnostic Agent / Radiopharmaceuticals | |
Quinupristin | 1022.23 C53H67N9O10S | An antibiotic agent used in the treatment of serious vancomycin-resistant Enterococcus faecium bacteremia as well as complicated skin and skin structure infections. | Anti-Bacterial Agents / Streptogramin Antibacterial | |
ILS-920 | 1023.315 C57H86N2O14 | ILS-920 is under investigation in clinical trial NCT00827190 (Study Evaluating Single Ascending Doses Of ILS-920). | Not Annotated | |
Flubentylosin | 1024.227 C53H82FNO17 | Not Annotated | Not Annotated | |
Mivacurium | 1029.2608 C58H80N2O14 | A short-acting non-depolarizing neuromuscular blocking agent used to induce anesthesia during intubation and promote skeletal muscle relaxation during surgery or mechanical ventilation. | Agents producing tachycardia | |
Temsirolimus | 1030.2871 C56H87NO16 | A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. | Mammalian target of rapamycin (mTOR) kinase inhibitors / Protein Kinase Inhibitors | |
Lodenafil carbonate | 1035.21 C47H62N12O11S2 | Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction. | Alkalies / Anions / Carbon Compounds, Inorganic / Carbonic Acid / Electrolytes / Ions | |
Doxacurium | 1035.2223 C56H78N2O16 | A nondepolarizing neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures. | Neuromuscular-Blocking Agents (Nondepolarizing) | |
Reltecimod | 1037.2 C46H72N10O15S | Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections). | Amino Acids, Peptides, and Proteins / Antigens / Antigens, Differentiation / Antigens, Differentiation, T-Lymphocyte / Antigens, Surface / Biological Factors / Biomarkers / Costimulatory and Inhibitory T-Cell Receptors / Membrane Proteins / Proteins | |
Thio-Maltohexaose | 1039.056 C36H62O28S3 | Not Available | Not Available |
Displaying drugs 12576 - 12600 of 12870 in total